BACKGROUND: Subcutaneous phaeohyphomycosis in solid organ recipients may have an adverse outcome. OBJECTIVE: We sought to describe the disease course, treatment, and outcome of allograft function in kidney transplant recipients with phaeohyphomycosis. METHODS: Seventeen patients were followed for a mean period of 25.4 months to analyze the clinical response to treatment. RESULTS: There was no treatment failure or relapsing disease among 12 patients who completed treatment. Two patients were still in treatment with disease remission. One patient discontinued the study during treatment with partial remission, one died after finishing treatment with disease remission, and one was dropped from the study because contact was lost. Immunosuppressive regimens were not changed. Two of 17 patients had a significant reduction in allograft function. LIMITATIONS: The follow-up time was short and the number of patients was small. CONCLUSIONS: The outcome of phaeohyphomycosis in kidney transplant recipients was favorable with minimal impact on renal allograft function.
BACKGROUND:Subcutaneous phaeohyphomycosis in solid organ recipients may have an adverse outcome. OBJECTIVE: We sought to describe the disease course, treatment, and outcome of allograft function in kidney transplant recipients with phaeohyphomycosis. METHODS: Seventeen patients were followed for a mean period of 25.4 months to analyze the clinical response to treatment. RESULTS: There was no treatment failure or relapsing disease among 12 patients who completed treatment. Two patients were still in treatment with disease remission. One patient discontinued the study during treatment with partial remission, one died after finishing treatment with disease remission, and one was dropped from the study because contact was lost. Immunosuppressive regimens were not changed. Two of 17 patients had a significant reduction in allograft function. LIMITATIONS: The follow-up time was short and the number of patients was small. CONCLUSIONS: The outcome of phaeohyphomycosis in kidney transplant recipients was favorable with minimal impact on renal allograft function.
Authors: Peggy A Wu; Maria L Turner; Edward W Cowen; Eleanor Wilson; Yvonne R Shea; Timothy Jancel; Alexandra F Freeman Journal: J Am Acad Dermatol Date: 2010-12 Impact factor: 11.527
Authors: Daniel W C L Santos; Ana Carolina B Padovan; Analy S A Melo; Sarah S Gonçalves; Viviane R Azevedo; Marilia M Ogawa; Tainá Veras Sandes Freitas; Arnaldo L Colombo Journal: Mycopathologia Date: 2013-01-04 Impact factor: 2.574
Authors: Marilia M Ogawa; Marcella P Peternelli; Milvia M S S Enokihara; Angela S Nishikaku; Sarah Santos Gonçalves; Jane Tomimori Journal: Mycopathologia Date: 2016-03-30 Impact factor: 2.574
Authors: Marilia Marufuji Ogawa; Mario Mariano; Maria Regina Regis Silva; Milvia Maria Simões E Silva Enokihara; Nilceo Schwery Michalany; Angela Satie Nishikaku; Agenor Messias Silvestre; Jane Tomimori Journal: An Bras Dermatol Date: 2019 Jan-Feb Impact factor: 1.896
Authors: Bassam H Rimawi; Ramzy H Rimawi; Meena Mirdamadi; Lisa L Steed; Richard Marchell; Deanna A Sutton; Elizabeth H Thompson; Nathan P Wiederhold; Jonathan R Lindner; M Sean Boger Journal: Med Mycol Case Rep Date: 2013-09-08
Authors: Guillaume Desoubeaux; Dania García; Eric Bailly; Olivier Augereau; Guillaume Bacle; Anne De Muret; Louis Bernard; José F Cano-Lira; Dea Garcia-Hermoso; Jacques Chandenier Journal: Med Mycol Case Rep Date: 2014-05-10